argenx SE (ARGX) stock
ARGXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$981.33+3.75 (+0.38%)
Close on Nov 12, 2026Market cap –P/E 50.1Yield –
argenx enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
argenx's enterprise value was $57.55B on Nov 11, 2026, against $53.70B a year earlier. Over the last 5 years it ranged from $12.26B to $60.93B, with a median of $27.15B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $57.55B | +16.6% |
| 2025 | Dec 31, 2025 | $49.35B | +39.7% |
| 2024 | Dec 31, 2024 | $35.34B | +75.1% |
| 2023 | Dec 29, 2023 | $20.18B | +3.5% |
| 2022 | Dec 30, 2022 | $19.49B | +18.7% |
| 2021 | Dec 31, 2021 | $16.42B | +34.5% |
| 2020 | Dec 31, 2020 | $12.20B | +123.8% |
| 2019 | Dec 31, 2019 | $5.45B | +76.4% |
| 2018 | Dec 31, 2018 | $3.09B | +143.3% |
| 2017 | Dec 29, 2017 | $1.27B | – |
See a number that looks wrong?